Pages

Wednesday, October 16, 2013

Regeneron, Sanofi 'Bad' Cholesterol Drug Passes Trial

... Sanofi and Regeneron also are working together to develop the cancer treatment Zaltrap as well as other products. Tarrytown, N.Y.-based Regeneron stock rose to an all-time high last month after Sanofi CEO Chris Viehbacher reiterated that Sanofi ...

http://news.investors.com/technology/101613-675310-regeneron-sanofi-report-good-results-for-cholesterol-drug.htm

No comments:

Post a Comment